返回
Hansoh Pharmaceutical Group Company Limited（3692.HK）價格
3692.HK 股價走勢圖
HANSOH PHARMA (3692.HK)
Hansoh Pharmaceutical Group Company Limited
HK$41.1
-3.33%
$-1.42
盤中： Jan 19, 13:33:43 HKT
Earnings FAQ
3692.HK 最近的每股盈餘與預期相比如何？
Hansoh Pharmaceutical Group Company Limited 3692.HK 上一季度的收入表現如何？
Hansoh Pharmaceutical Group Company Limited 的收入預期是多少？
Hansoh Pharmaceutical Group Company Limited 的盈利品質評分是多少？
Hansoh Pharmaceutical Group Company Limited 何時發布財報？
Hansoh Pharmaceutical Group Company Limited 的預期收益是多少？
Hansoh Pharmaceutical Group Company Limited 是否超出收益預期？
關鍵數據
前收市價
$43
開盤價
$42.52
當日範圍
$40.74 - $43.42
52週區間
$16.7 - $44.22
交易量
3.0M
平均成交量
8.3M
每股盈餘 (TTM)
0.89
股息收益率
--
市值
$244.3B
什麼是 HANSOH PHARMA？
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,313 full-time employees. The company went IPO on 2019-06-14. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The firm mainly conducts its business in the domestic market.